Stockscreener 앱 받기
6.30
0.64%
0.04
시간 외 거래:
6.30
전일 마감가:
$6.26
열려 있는:
$6.27
하루 거래량:
238.07K
Relative Volume:
0.56
시가총액:
$418.05M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-10.50
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
-7.49%
1개월 성능:
-3.82%
6개월 성능:
-38.42%
1년 성능:
-12.13%
1일 변동 폭
$6.26
$6.46
1주일 범위
$6.26
$6.84
52주 변동 폭
$6.02
$14.38
Bioventus Inc Stock (BVS) Company Profile
명칭
Bioventus Inc
전화
(919) 474-6700
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.30 | 451.90M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-07 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2022-11-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-11-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 개시 | Craig Hallum | Buy |
| 2021-11-15 | 재개 | Morgan Stanley | Overweight |
| 2021-11-10 | 재개 | JP Morgan | Overweight |
| 2021-07-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-08 | 개시 | Canaccord Genuity | Buy |
| 2021-03-08 | 개시 | Goldman | Buy |
| 2021-03-08 | 개시 | JP Morgan | Overweight |
| 2021-03-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioventus Inc 주식(BVS)의 최신 뉴스
What drives Bioventus Inc. stock priceExceptional portfolio growth - Autocar Professional
Bioventus (NASDAQ:BVS) Cut to “Buy” at Wall Street Zen - Defense World
What analysts say about Bioventus Inc. stockRapid wealth multiplication - PrintWeekIndia
Bioventus Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating - MSN
Is Bioventus Inc. a good long term investmentAccelerated investment success - jammulinksnews.com
Bioventus (NASDAQ:BVS) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Analysts Expect Bioventus Inc. (NASDAQ:BVS) To Breakeven Soon - simplywall.st
What makes Bioventus Inc. stock price move sharplyFree Best Performing Stock Alerts - beatles.ru
why bioventus inc. stock attracts strong analyst attentionWeekly Big Movers - newser.com
Why Bioventus Inc. stock attracts strong analyst attentionFree Stock Market Strategy Classes - Newser
How Bioventus Inc. stock performs during market volatilityFree Market Dynamics Reports - Newser
10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey
Allspring Global Investments Holdings LLC Raises Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
With 36% stake, Bioventus Inc. (NASDAQ:BVS) seems to have captured institutional investors' interest - Yahoo Finance
How the (BVS) price action is used to our Advantage - news.stocktradersdaily.com
Bioventus(BVS) Shares Soar 3.54% on Pipeline Progress - AInvest
Cantor Fitzgerald Initiates Coverage on Bioventus (NYSE:BVS) - Defense World
Cantor Fitzgerald initiates Bioventus stock with Overweight rating on growth potential By Investing.com - Investing.com South Africa
Cantor Fitzgerald initiates Bioventus stock with Overweight rating on growth potential - Investing.com Nigeria
Cartilage Repair Regeneration Market is Going To Boom | Zimmer Biomet, Bioventus - newstrail.com
Bioventus' Bold Bet on Core Markets: A Strategic Shift With High Stakes - AInvest
BVS: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
(BVS) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Do Options Traders Know Something About Bioventus Stock We Don't? - The Globe and Mail
(BVS) Proactive Strategies - news.stocktradersdaily.com
Bone Growth Stimulator Market Booming Worldwide with - openPR.com
bioventus inc. reports results of annual stockholders meeting By Investing.com - Investing.com South Africa
bioventus inc. reports results of annual stockholders meeting - Investing.com
Bioventus Holds Annual Meeting, Elects Directors - TipRanks
Cetera Investment Advisers Sells 1,805 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week
Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus Inc (BVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):